Notably, in the pathway of Figure 3B, among the deregulated genes detected in response to treatment with LSL60101, we can observe a reduction in Tnf-α and Il-6, two cytokines with high expression in the development of AD [33]. This evidence concerns the gene IL6 and Alzheimer disease.